Quinoline-based antimalarial drugs: A novel class of autophagy inhibitors

Neurosurgical Focus

Volumn 38, Issue 3, 2015, Pages

  Golden, Encouse B ^a   Cho, Hee Yeon ^b   Hofman, Florence M ^b   Louie, Stan G ^c   Schönthal, Axel H ^b   Chen, Thomas C ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antimalaria compound; Autophagy; Chloroquine; Endoplasmic reticulum stress; Glioma

Indexed keywords

ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; QUINOLINE; QUINOLINE DERIVATIVE;

ANIMAL; APOPTOSIS; AUTOPHAGY; BRAIN NEOPLASMS; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION; GLIOMA; HUMAN; METABOLISM; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIMALARIALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICE, NUDE; POLY(ADP-RIBOSE) POLYMERASES; QUINOLINES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84929648600     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2014.12.FOCUS14748     Document Type: Article

References (42)

1. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, et al: Autophagy inhibition enhances therapyinduced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117:326-336, 2007.
2. Bachhawat K, Thomas CJ, Surolia N, Surolia A: Interaction of chloroquine and its analogues with heme: an isothermal titration calorimetric study. Biochem Biophys Res Commun 276:1075-1079, 2000.
3. Baird JK: Effectiveness of antimalarial drugs. N Engl J Med 352:1565-1577, 2005.
4. Baranova AM: [Current antimalarial drugs recommended by the World Health Organization for the treatment and prevention of malaria.] Med Parazitol (Mosk) 3:56-59, 2007 (Russian).
5. Barraud de Lagerie S, Comets E, Gautrand C, Fernandez C, Auchere D, Singlas E, et al: Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice. Br J Pharmacol 141:1214-1222, 2004.
6. Briceño E, Calderon A, Sotelo J: Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme. Surg Neurol 67:388-391, 2007.
7. Brocks DR, Mehvar R: Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs. Clin Pharmacokinet 42:1359-1382, 2003.
8. Bursch W, Karwan A, Mayer M, Dornetshuber J, Fröhwein U, Schulte-Hermann R, et al: Cell death and autophagy: cytokines, drugs, and nutritional factors. Toxicology 254:147-157, 2008.
9. Carew JS, Nawrocki ST, Cleveland JL: Modulating autophagy for therapeutic benefit. Autophagy 3:464-467, 2007.
10. Caridha D, Yourick D, Cabezas M, Wolf L, Hudson TH, Dow GS: Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin. Antimicrob Agents Chemother 52:684-693, 2008.
11. Chauhan PM, Srivastava SK: Present trends and future strategy in chemotherapy of malaria. Curr Med Chem 8:1535-1542, 2001.
12. Chen N, Karantza-Wadsworth V: Role and regulation of au-tophagy in cancer. Biochim Biophys Acta 1793:1516-1523, 2009.
13. Cho HY, Thomas S, Golden EB, Gaffney KJ, Hofman FM, Chen TC, et al: Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress. Cancer Lett 282:87-97, 2009.
14. Cho HY, Wang W, Jhaveri N, Lee DJ, Sharma N, Dubeau L, et al: NEO212, temozolomide conjugated to perillyl alcohol, is a novel drug for effective treatment of a broad range of temozolomide-resistant gliomas. Mol Cancer Ther 13: 2004-2017, 2014.
15. Degtyarev M, De Mazière A, Orr C, Lin J, Lee BB, Tien JY, et al: Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J Cell Biol 183:101-116, 2008.
16. Dow GS, Caridha D, Goldberg M, Wolf L, Koenig ML, Yourick DL, et al: Transcriptional profiling of mefloquine-induced disruption of calcium homeostasis in neurons in vitro. Genomics 86:539-550, 2005.
17. Easterbrook M: Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 39:49-57, 1999.
18. Elliott DA, McIntosh MT, Hosgood HD III, Chen S, Zhang G, Baevova P, et al: Four distinct pathways of hemoglobin uptake in the malaria parasite Plasmodium falciparum. Proc Natl Acad Sci U S A 105:2463-2468, 2008.
19. Fitch CD, Russell NV: Accelerated denaturation of hemoglobin and the antimalarial action of chloroquine. Antimicrob Agents Chemother 50:2415-2419, 2006.
20. Frosch T, Schmitt M, Bringmann G, Kiefer W, Popp J: Structural analysis of the anti-malaria active agent chloroquine under physiological conditions. J Phys Chem B 111:1815-1822, 2007.
21. Gayrard V, Picard-Hagen N, Viguié C, Laroute V, Andréoletti O, Toutain PL: A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie. Br J Pharmacol 144:386-393, 2005.
22. Golenser J, McQuillan J, Hee L, Mitchell AJ, Hunt NH: Conventional and experimental treatment of cerebral malaria. Int J Parasitol 36:583-593, 2006.
23. Hegi ME, Liu L, Herman JG, Stupp R, Wick W, Weller M, et al: Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26:4189-4199, 2008.
24. Kardosh A, Golden EB, Pyrko P, Uddin J, Hofman FM, Chen TC, et al: Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. Cancer Res 68:843-851, 2008.
25. Kardosh A, Soriano N, Liu YT, Uddin J, Petasis NA, Hofman FM, et al: Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib. Blood 106:4330-4338, 2005.
26. Lazarus MD, Schneider TG, Taraschi TF: A new model for hemoglobin ingestion and transport by the human malaria parasite Plasmodium falciparum. J Cell Sci 121:1937-1949, 2008.
27. Lim HS, Im JS, Cho JY, Bae KS, Klein TA, Yeom JS, et al: Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax. Antimicrob Agents Chemother 53: 1468-1475, 2009.
28. Maguire JD, Krisin, Marwoto H, Richie TL, Fryauff DJ, Baird JK: Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia. Clin Infect Dis 42:1067-1072, 2006.
29. Marceau F, Bawolak MT, Bouthillier J, Morissette G: Vacuolar ATPase-mediated cellular concentration and retention of quinacrine: a model for the distribution of lipophilic cationic drugs to autophagic vacuoles. Drug Metab Dispos 37:2271-2274, 2009.
30. Münz C: Enhancing immunity through autophagy. Annu Rev Immunol 27:423-449, 2009.
31. Orvedahl A, Levine B: Eating the enemy within: autophagy in infectious diseases. Cell Death Differ 16:57-69, 2009.
32. Pham YT, Nosten F, Farinotti R, White NJ, Gimenez F: Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int J Clin Pharmacol Ther 37:58-61, 1999.
33. Sanchez CP, McLean JE, Stein W, Lanzer M: Evidence for a substrate specific and inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains. Biochemistry 43:16365-16373, 2004.
34. Schönthal AH: Endoplasmic reticulum stress and autophagy as targets for cancer therapy. Cancer Lett 275:163-169, 2009.
35. Sharma N, Thomas S, Golden EB, Hofman FM, Chen TC, Petasis NA, et al: Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer Lett 326:143-154, 2012.
36. Shono T, Tofilon PJ, Schaefer TS, Parikh D, Liu TJ, Lang FF: Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation. Cancer Res 62:1069-1076, 2002.
37. Slater AF: Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol Ther 57:203-235, 1993.
38. Sprangers R, Li X, Mao X, Rubinstein JL, Schimmer AD, Kay LE: TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors. Biochemistry 47:6727-6734, 2008.
39. Tsuchihara K, Fujii S, Esumi H: Autophagy and cancer: dynamism of the metabolism of tumor cells and tissues. Cancer Lett 278:130-138, 2009.
40. Warhurst DC, Craig JC, Adagu IS, Meyer DJ, Lee SY: The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids. Malar J 2:26, 2003.
41. Webster RV, Craig JC, Shyamala V, Kirby GC, Warhurst DC: Antimalarial activity of optical isomers of quinacrine dihydrochloride against chloroquine-sensitive and-resistant Plasmodium falciparum in vitro. Biochem Pharmacol 42 Suppl:S225-S227, 1991.
42. Zagzag D, Nomura M, Friedlander DR, Blanco CY, Gagner JP, Nomura N, et al: Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion. J Cell Physiol 196:394-402, 2003.